Sutter Health California Pacific Medical Center is a general medical/surgical and teaching hospital in San Francisco, California. It was created by a merger of some of the city's longest established hospitals and currently operates three acute care campuses.

During the past decade, California Pacific Medical Center conducted 152 clinical trials. In the 10-year time frame, 152 clinical trials started and 183 clinical trials were completed, i.e. on average, 120.4% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 88 clinical trials were completed. i.e. 283.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "California Pacific Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 94 trials, followed by "SWOG Cancer Research Network" with 53 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "California Pacific Medical Center Research Institute" with 11 trials sponsored and "Gilead Sciences" with 11 trials sponsored. Other sponsors include 244 different institutions and companies that sponsored additional 141 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "California Pacific Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 117 trials as a collaborator, "NRG Oncology" with 33 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 152 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "California Pacific Medical Center" are "Amyotrophic Lateral Sclerosis" (22 trials), "Breast Cancer" (19 trials), "Prostate Cancer" (13 trials), "Hepatitis B" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "California Pacific Medical Center" in a lesser frequency.

Most popular intervention types in "California Pacific Medical Center" are "Drug" (321 trials), "Other" (149 trials), "Biological" (111 trials), "Procedure" (55 trials) and "Radiation" (41 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "Placebo" (51 trials), "Quality-of-Life Assessment" (46 trials), "Paclitaxel" (33 trials) and "Bevacizumab" (26 trials). Other intervention names were less common.

The vast majority of trials in "California Pacific Medical Center" are 367 trials for "All" genders, 55 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "California Pacific Medical Center". undefined are not yet recruiting, 45 are recruiting, 111 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 228 completed trials in California Pacific Medical Center, 2 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in California Pacific Medical Center, 34 "Phase 1" clinical trials were conducted, 173 "Phase 2" clinical trials and 194 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 36 trials that are defined as “Not Applicable".

California Pacific Medical Center has several departments that took part in Clinical trials: "Sutter Cancer Research Consortium" - 128 trials, "Sutter Cancer Centers Radiation Oncology Services-Roseville" - 125 trials, "Sutter Breast Cancer Group" - 2 trials, "Bay Area Structural Heart at Sutter Health" - 2 trials